CDC Anthrax | Surveillance & Investigation


Emergency Preparedness & Response

Agents, Diseases, & Other Threats

•

Bioterrorism Agents

Anthrax
•	Anthrax Basics:
	-	Questions & Answers
	-	Fact Sheets & Overviews
	-	Mail Handlers
•	In-Depth Info & Resources:
	-	Diagnosis/ Evaluation
	-	Environment/ Response
	-	Exposure Management/ Prophylaxis
	-	Images
	-	Infection Control
	-	Lab Testing
	-	Preparation & Planning
	-	References
	-	Surveillance & Investigation
	-	Training
	-	Treatment
	-	Vaccination
	-	Work Safety

•

Chemical Agents

•

Mass Trauma

•

Natural Disasters

•

Radiation Emergencies

•

Recent Outbreaks & Incidents

	Lab Information
	Training
	Preparation & Planning
	Surveillance
	Preparedness & Children
	News
	Related Links

Preparación y respuesta para casos de emergencia

Anthrax Home >

Anthrax: Surveillance and Investigation

Title	Date Last Revised
*MMWR: Responding to Detection of Aerosolized Bacillus anthracis* by Autonomous Detection Systems in the Workplace MMWR 2004 Apr 30;53(Early Release):1-11.**	Apr 30, 2004
*MMWR: Follow-Up of Deaths Among U.S. Postal Service Workers Potentially Exposed to Bacillus anthracis—District of Columbia, 2001–2002* MMWR 2003 Oct 3;52(39):937-938. PDF (470 KB/20 pages)	Oct 3, 2003
Isolated Case of Bioterrorism-related Inhalational Anthrax, New York City, 2001 Emerging Infectious Diseases 2003 June;9(6):689-692.	Jun 2003
Bioterrorism-related Inhalational Anthrax in an Elderly Woman, Connecticut, 2001 Emerging Infectious Diseases 2003 June;9(6):681-688.	Jun 2003
Endemic, Notifiable Bioterrorism-Related Diseases, United States, 1992�1999 Emerging Infectious Diseases 2003 May;9(5):556-564.	May 2003
Investigation of Bioterrorism-Related Anthrax, United States, 2001: Epidemiologic Findings Emerging Infectious Diseases 2002 Oct;8(10):1019-1028.	Oct 2002
First Case of Bioterrorism-Related Inhalational Anthrax in the United States, Palm Beach County, Florida, 2001 Emerging Infectious Diseases 2002 Oct;8(10):1029-1034.	Oct 2002
First Case of Bioterrorism-Related Inhalational Anthrax, Florida, 2001: North Carolina Investigation Emerging Infectious Diseases 2002 Oct;8(10):1035-1038.	Oct 2002
*Opening a Bacillus anthracis–Containing Envelope, Capitol Hill, Washington, D.C.: The Public Health Response* Emerging Infectious Diseases 2002 Oct;8(10):1039-1043.	Oct 2002
Inhalational Anthrax Outbreak among Postal Workers, Washington, D.C., 2001 Emerging Infectious Diseases 2002 Oct;8(10):1066-1072.	Oct 2002
Epidemiologic Investigations of Bioterrorism-Related Anthrax, New Jersey, 2001 Emerging Infectious Diseases 2002 Oct;8(10):1048-1055.	Oct 2002
Surveillance for Anthrax Cases Associated with Contaminated Letters, New Jersey, Delaware, & Pennsylvania, 2001 Emerging Infectious Diseases 2002 Oct;8(10):1073-1077.	Oct 2002
Bioterrorism-Related Anthrax Surveillance, Connecticut, September–December, 2001 Emerging Infectious Diseases 2002 Oct;8(10):1078-1082.	Oct 2002
Call-Tracking Data & the Public Health Response to Bioterrorism-Related Anthrax Emerging Infectious Diseases 2002 Oct;8(10):1088-1092.	Oct 2002
Coordinated Response to Reports of Possible Anthrax Contamination, Idaho, 2001 Emerging Infectious Diseases 2002 Oct;8(10):1093-1095.	Oct 2002
Bioterrorism-Related Anthrax: International Response by the Centers for Disease Control & Prevention Emerging Infectious Diseases 2002 Oct;8(10):1056-1059.	Oct 2002
Laboratory Response to Anthrax Bioterrorism, New York City, 2001 Emerging Infectious Diseases 2002 Oct;8(10):1096-1102.	Oct 2002
Use of Automated Ambulatory-Care Encounter Records for Detection of Acute Illness Clusters, Including Potential Bioterrorism Events Emerging Infectious Diseases 2002 Aug;8(8):753-760.	Aug 2002
MMWR: Investigation of Bioterrorism-Related Anthrax – Connecticut, 2001 MMWR 2001 Dec 7;50(48):1077-1079. PDF (144 KB/24 pages)	Dec 7, 2001
MMWR: Investigation of Bioterrorism-Related Inhalational Anthrax – Connecticut, 2001 MMWR 2001 Nov 30;50(47):1049-1051. PDF (252 KB/28 pages)	Nov 30, 2001
MMWR: Investigation of Bioterrorism-Related Anthrax, 2001 MMWR 2001 Nov 16;50(45):1008-1010. PDF (262 KB/24 pages)	Nov 16, 2001
MMWR: Investigation of Bioterrorism-Related Anthrax & Adverse Events from Antimicrobial Prophylaxis MMWR 2001 Nov 9;50(44):973-976. PDF (194 KB/32 pages)	Nov 9, 2001
MMWR: Recognition of Illness Associated with the Intentional Release of a Biologic Agent MMWR 2001 Oct 19;50(41):893-897. PDF (168 KB/20 pages)	Oct 19, 2001
MMWR: Surveillance for Adverse Events Associated with Anthrax Vaccination – U.S. Department of Defense, 1998-2000 MMWR 2000 Apr 28;49(16):341-345. PDF (286 KB/24 pages)	Apr 28, 2000
Case Definition (Fact Sheet: Anthrax Information for Health Care Providers) For professionals. Includes causes, systems affected, transmission...	Mar 8, 2002
An Anthrax Outbreak Averted: Public Health Response to a Contaminated Envelope on Capitol Hill, Washington, DC, 2001 Archived video webcast from the International Conference on Emerging Infectious Diseases (ICEID) Vincent Hsu, CDC, Atlanta, GA	Mar 26, 2002
Inhalational Anthrax—New York City, October–November 2001 Archived video webcast from the International Conference on Emerging Infectious Diseases (ICEID) Timothy Holtz, CDC & New York City Department of Health, New York, NY	Mar 26, 2002
Letters from Trenton: The Anthrax Investigation at the Source, New Jersey, 2001 Archived video webcast from the International Conference on Emerging Infectious Diseases (ICEID) Jennita Reefhuis, CDC, Atlanta, GA	Mar 26, 2002


		This page last reviewed April 30, 2004